Bayer HealthCare AG - Product Pipeline Analysis

Date: August 13, 2012
Pages: 50
Price:
US$ 750.00
License [?]:
Publisher: GlobalData
Report type: Company Report
Delivery: E-mail Delivery (PDF)
ID: BACB18A39F2EN
Leaflet:

Download PDF Leaflet

Bayer HealthCare AG - Product Pipeline Analysis
Bayer HealthCare AG - Product Pipeline Analysis

Summary

Bayer HealthCare AG (Bayer Healthcare), a division of the Bayer Group is a healthcare company. It undertakes the design, research, development, manufacture and sale of medical products for the healthcare industry. The company develops innovative products such as animal healthcare products, consumer care products, blood glucose monitoring systems, diagnostic imaging products, oncology products and primary care products. It operates through four business divisions, namely, Animal Health, Consumer Care, Medical Care and Pharmaceuticals. Bayer Healthcare’s products are marketed across the world through regional and national distribution companies. It operates in more than 100 countries and has about 60 manufacturing facilities across five continents. The company is headquartered in Leverkusen, Germany.

Bayer Healthcare focuses on enhancing its market share through strategic alliances and acquisitions. In line with this strategy, the company recently collaborated with Covance; and acquired animal health business of KMG Chemicals.

This report is a source for data, analysis and actionable intelligence on the Bayer HealthCare AG portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope
  • Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
  • Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
  • Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
  • Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
  • Data on relevant clinical trials and product patent details, wherever applicable.
  • Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Develop competition strategies by identifying the status and likely launch of your competitors’ pipeline products through review of the clinical trials, stage and phase of development, etc.
  • Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize.
Bayer HealthCare AG - Business Description
Key Facts
Bayer HealthCare AG - Major Products and Services
Bayer HealthCare AG Pipeline Products by Equipment Type
Bayer HealthCare AG Pipeline Products by Development Stage
Bayer HealthCare AG Pipeline Products by Therapy Area
Bayer HealthCare AG Pipeline Products by Trial Phase
Bayer HealthCare AG Pipeline Products by Milestone Summary
Bayer Blood Glucose Monitoring System
Bayer Blood Glucose Monitoring System Product Status
Bayer Blood Glucose Monitoring System Product Description
Ciprofloxacin Dry Powder Inhaler
Ciprofloxacin Dry Powder Inhaler Product Status
Ciprofloxacin Dry Powder Inhaler Product Description
Ciprofloxacin Dry Powder Inhaler Product Patent Details
CONTOUR Next EZ Blood Glucose Monitoring System
CONTOUR Next EZ Blood Glucose Monitoring System Product Status
CONTOUR Next EZ Blood Glucose Monitoring System Product Description
CONTOUR Next EZ Blood Glucose Monitoring System Product Milestone
CONTOUR Next EZ Blood Glucose Monitoring System Clinical Trial
Contrast Agent Injection System
Contrast Agent Injection System Product Status
Contrast Agent Injection System Product Description
FC Patch Low
FC Patch Low Product Status
FC Patch Low Product Description
FC Patch Low Product Milestone
FC Patch Low Clinical Trial
LCS-12
LCS-12 Product Status
LCS-12 Product Description
LCS-12 Product Milestone
LCS-16
LCS-16 Product Status
LCS-16 Product Description
Silica Gel Wound Dressing
Silica Gel Wound Dressing Product Status
Silica Gel Wound Dressing Product Description
Silica Gel Wound Dressing Product Milestone
Silica Gel Wound Dressing Clinical Trial
Thrombectomy System
Thrombectomy System Product Status
Thrombectomy System Product Description
Bayer HealthCare AG - Key Competitors
Bayer HealthCare AG - Key Employees
Bayer HealthCare AG - Key Employee Biographies
Bayer HealthCare AG - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Bayer HealthCare AG, Recent Developments
Jul 10, 2012: Bayer Announces 2012 Recipients Of Bayer Hemophilia Awards Program
Jul 02, 2012: Bayer To Present Data On Hemophilia Research At WFH 2012 World Congress
Mar 28, 2012: Bayer To Present New Data On Oncology Pipeline
Jan 27, 2012: Bayer Receives Approval From EU Authorities To Use Gadovist 1.0 In Children Aged Two Years And Older
Jan 19, 2012: Bayer HealthCare Expands Research And Manufacturing Capabilities For Interventional Franchise
Jan 09, 2012: Bayer HealthCare To Share Lab Space With Start-Up Companies
Jan 04, 2012: Intendis Changes Name To Bayer HealthCare
Aug 15, 2011: Bayer To Support WHO And Stop Tuberculosis Partnership In Fighting Tuberculosis
Apr 04, 2011: Bayer HealthCare Selects State Of New Jersey For East Coast Site Consolidation
Apr 01, 2011: Bayer To Present Data On Oncology Pipeline
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Bayer HealthCare AG, Key Facts
Bayer HealthCare AG Key Pipeline Products by Equipment Type
Bayer HealthCare AG Key Pipeline Products by Therapy Area
Bayer HealthCare AG Key Pipeline Products by Development Stage
Bayer HealthCare AG Key Pipeline Products by Trial Phase
Bayer HealthCare AG, Key Facts
Bayer HealthCare AG, Major Products and Services
Bayer HealthCare AG Number of Pipeline Products by Equipment Type
Bayer HealthCare AG Pipeline Products by Equipment Type
Bayer HealthCare AG Number of Pipeline Products by Development Stage
Bayer HealthCare AG Pipeline Products by Development Stage
Bayer HealthCare AG Number of Pipeline Products by Therapy Area
Bayer HealthCare AG Pipeline Products by Therapy Area
Bayer HealthCare AG Number of Pipeline Products by Trial Phase
Bayer HealthCare AG Pipeline Products by Trial Phase
Bayer HealthCare AG Number of Pipeline Products By Milestone Summary
Bayer HealthCare AG Pipeline Products by Milestone Summary
Bayer Blood Glucose Monitoring System - Product Status
Bayer Blood Glucose Monitoring System - Product Description
Ciprofloxacin Dry Powder Inhaler - Product Status
Ciprofloxacin Dry Powder Inhaler - Product Description
Ciprofloxacin Dry Powder Inhaler - Patent Details1
CONTOUR Next EZ Blood Glucose Monitoring System - Product Status
CONTOUR Next EZ Blood Glucose Monitoring System - Product Description
CONTOUR Next EZ Blood Glucose Monitoring System - Product Milestone
CONTOUR Next EZ Blood Glucose Monitoring System - A Clinical Trial Evaluating the Use of the CONTOUR Next EZ BGM System
Contrast Agent Injection System - Product Status
Contrast Agent Injection System - Product Description
FC Patch Low - Product Status
FC Patch Low - Product Description
FC Patch Low - Product Milestone
FC Patch Low - Multi-Center, Open, Randomized, Parallel Group Comparison of Cycle Control for Seven Cycles and Endometrial Safety in a Subgroup for Thirteen Cycles of Contraceptive Patch SH P00331F ( vs a Contraceptive Comparator Patch in 400 Healthy Female Volunteers)
FC Patch Low - A Single-Center, Open-Label, Crossover, Randomized Study to Investigate the Impact of the Transdermal Contraceptive Patch
FC Patch Low - Transdermal Contraception Patch: EU Cycle Control Study Versus EVRA
LCS-12 - Product Status
LCS-12 - Product Description
LCS-12 - Product Milestone
LCS-16 - Product Status
LCS-16 - Product Description
Silica Gel Wound Dressing - Product Status
Silica Gel Wound Dressing - Product Description
Silica Gel Wound Dressing - Product Milestone
Silica Gel Wound Dressing - Clinical Trial to Evaluate Silica Gel Wound Dressing in Patients Suffering from Chronic Venous Leg Ulcers
Silica Gel Wound Dressing - Randomized Standard-of-Care-Controlled Trial of a Silica Gel Fiber (SGF) Wound Dressing in the Treatment of Chronic Venous Leg Ulcers
Thrombectomy System - Product Status
Thrombectomy System - Product Description
Bayer HealthCare AG, Key Employees
Bayer HealthCare AG, Key Employee Biographies
Bayer HealthCare AG, Other Locations
Bayer HealthCare AG, Subsidiaries

LIST OF FIGURES

Bayer HealthCare AG Key Pipeline Products by Equipment Type
Bayer HealthCare AG Pipeline Products by Equipment Type
Bayer HealthCare AG Pipeline Products by Development Stage
Bayer HealthCare AG Pipeline Products by Therapy Area
Bayer HealthCare AG Pipeline Products by Trial Phase
Bayer HealthCare AG Pipeline Products by Milestone Summary
Bayer HealthCare AG - Strategic SWOT Analysis Review US$ 125.00 May, 2014 · 45 pages
Siemens Healthcare - Product Pipeline Analysis US$ 750.00 May, 2012 · 280 pages
GE Healthcare - Product Pipeline Analysis US$ 750.00 May, 2012 · 70 pages
Philips Healthcare - Product Pipeline Analysis US$ 750.00 Jun, 2012 · 57 pages

Ask Your Question

Bayer HealthCare AG - Product Pipeline Analysis
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: